152 related articles for article (PubMed ID: 9324798)
1. [The diagnosis and clinical characteristics of cytomegalovirus infection in HIV-infected subjects].
Shakhgil'dian VI; Kravchenko AV; Shipulina OIu; Marchenko NR; Ermak TN; Iurin OG; Stakhanova VM; Parkhomenko IuG; Karazhas NV; Evseeva LF; Gruzdev BM; Pokrovskiĭ VV
Ter Arkh; 1996; 68(4):65-8. PubMed ID: 9324798
[TBL] [Abstract][Full Text] [Related]
2. [Tuberculosis in patients with HIV infection].
Kravchenko AV; Iurin OG; Alekseeva LP; Utekhin VA; Ermak TN; Serebrovskaia LV; Shakhgil'dian VI; Roslyĭ IM; Parkhomenko IuG; Serova VV; Gruzdev BM; Burchik MA; Pokrovskiĭ VV
Ter Arkh; 1996; 68(4):69-71. PubMed ID: 9324799
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
4. Evidence of active cytomegalovirus infection in clinically stable HIV-infected individuals with CD4+ lymphocyte counts below 100/microliters of blood: features and relation to risk of subsequent CMV retinitis.
MacGregor RR; Pakola SJ; Graziani AL; Montzka DP; Hodinka RL; Nichols CW; Friedman HM
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):324-30. PubMed ID: 7552494
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
[TBL] [Abstract][Full Text] [Related]
6. CMV PCR in leucocytes as an early marker for the development of CMV disease in AIDS patients.
Quarner H; Grützmeier S; Lewensohn-Fuchs I; Hejdeman B; Sandström E; Ehrnst A
Scand J Infect Dis Suppl; 1995; 99():94-5. PubMed ID: 8668950
[TBL] [Abstract][Full Text] [Related]
7. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).
Erice A; Tierney C; Hirsch M; Caliendo AM; Weinberg A; Kendall MA; Polsky B;
Clin Infect Dis; 2003 Aug; 37(4):567-78. PubMed ID: 12905142
[TBL] [Abstract][Full Text] [Related]
9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
11. [Cytomegalovirus infection of the gastrointestinal tract in patients with HIV-infection].
Shagil'dian VI; Tishkevich OA; Parkhomenko IuG; Morozova SV; Tishkevich IM; Gruzdev BM; Danilova TV; Golokhvastova EL
Ter Arkh; 2005; 77(11):14-20. PubMed ID: 16404855
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).
Steininger C; Puchhammer-Stöckl E; Popow-Kraupp T
J Clin Virol; 2006 Sep; 37(1):1-9. PubMed ID: 16675299
[TBL] [Abstract][Full Text] [Related]
13. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
14. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells.
Bronke C; Westerlaken GH; Miedema F; Tesselaar K; van Baarle D
Immunol Lett; 2005 Mar; 97(2):215-24. PubMed ID: 15752561
[TBL] [Abstract][Full Text] [Related]
15. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Tufail A; Moe AA; Miller MJ; Wagar EA; Bruckner DA; Holland GN
Ophthalmology; 1999 Jan; 106(1):133-41. PubMed ID: 9917794
[TBL] [Abstract][Full Text] [Related]
16. [Infection by cytomegalovirus in patients with acquired immunodeficiency syndrome (AIDS): clinical, virological, and histopathological correlations].
Turchi MD; Pannuti CS; Sumita LM; Vilas Boas LS; Weinberg A; Stavale JN; Borges AF; Collarine DC; dos Santos HV; Kitadai SS
Rev Inst Med Trop Sao Paulo; 1991; 33(4):243-50. PubMed ID: 1668973
[TBL] [Abstract][Full Text] [Related]
17. Laboratory diagnosis of cytomegalovirus (CMV) infections in immunodepressed patients, mainly in patients with AIDS.
Tendero DT
Clin Lab; 2001; 47(3-4):169-83. PubMed ID: 11294581
[TBL] [Abstract][Full Text] [Related]
18. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
[TBL] [Abstract][Full Text] [Related]
19. Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.
Gordon M; Deeks S; De Marzo C; Goodgame J; Guralnik M; Lang W; Mimura T; Pearce D; Kaneko Y
J Med; 1997; 28(1-2):108-28. PubMed ID: 9249617
[TBL] [Abstract][Full Text] [Related]
20. [Indications for eye examination of HIV patients--screening parameters for cytomegalovirus retinitis].
Gellrich MM; Lagrèze WD; Rump JA; Hansen LL
Klin Monbl Augenheilkd; 1996; 209(2-3):72-8. PubMed ID: 8992086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
